Ignite Creation Date:
2024-05-06 @ 8:27 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02745522
Status:
COMPLETED
Last Update Posted:
2018-10-15
First Post:
2016-03-11
Brief Title:
Can Oxytocin Enhance the Placebo Effect
Sponsor:
University of Electronic Science and Technology of China
Organization:
University of Electronic Science and Technology of China
Study Overview
Official Title:
Can Oxytocin Enhance the Placebo Effect
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current study aimed to investigate whether oxytocin OXT had effect on placebo effect
Detailed Description:
The current study included three phases to investigate oxytocin effect on placebo effect
1 In a double-blind between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 66 healthy male subjects using working memory task
2 In a single-blindsubjects were informed that the treatment was oxytocin between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 53 healthy male subjects using working memory taskThey were informed that oxytocin would increase memory perfomance by a female experimenter
3 In a single-blindsubjects were informed that the treatment was oxytocin between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 53 healthy male subjects using working memory task But the subjects were told that oxytocin would decrease the performance by the same female experimenter
4 In a single-blindsubjects were informed that the treatment was oxytocin between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 52 healthy male subjects using working memory task The subjects were told that oxytocin would increase the performance by a male experimenter
Memory performance was included as dependant factor All subjects completed a range of questionnaires measuring personality and affective traits and levels of anxiety State-Trait Anxiety Inventory STAI Beck Depression Inventory BDI Interpersonal Trust ScaleITS
1 In a double-blind between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 66 healthy male subjects using working memory task
2 In a single-blindsubjects were informed that the treatment was oxytocin between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 53 healthy male subjects using working memory taskThey were informed that oxytocin would increase memory perfomance by a female experimenter
3 In a single-blindsubjects were informed that the treatment was oxytocin between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 53 healthy male subjects using working memory task But the subjects were told that oxytocin would decrease the performance by the same female experimenter
4 In a single-blindsubjects were informed that the treatment was oxytocin between-subject placebo controlled design study to investigate the intranasal OXT 24IU treatment in 52 healthy male subjects using working memory task The subjects were told that oxytocin would increase the performance by a male experimenter
Memory performance was included as dependant factor All subjects completed a range of questionnaires measuring personality and affective traits and levels of anxiety State-Trait Anxiety Inventory STAI Beck Depression Inventory BDI Interpersonal Trust ScaleITS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None